The Valley Desk

ArticleCancer lettersPublished

Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathway

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Cancer letters
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Carcinoma, Renal Cell; Kidney Neoplasms; Sulfonamides; Aniline Compounds; Xenograft Model Antitumor Assays; Signal Transduction; Apoptosis; STAT3 Transcription Factor
PubMed ID
39894195
PubMed Central ID
PMC12236298
Added to directory
Source checked

Report a correction or request removal